Editas Medicine (EDIT) Net Margin (2015 - 2025)
Editas Medicine (EDIT) reported Net Margin of 332.97% for Q3 2025, up 10152932.0% year-over-year from N/an in Q3 2024, and up 76.86% on a QoQ basis from 1438.71% in Q2 2025.
Editas Medicine (EDIT) has 11 years of Net Margin data on file, last reported at 332.97% in Q3 2025.
- Quarterly Net Margin rose 10152932.0% year-over-year to 332.97% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 426.12% (down 8518.0% YoY) and the FY2024 annual result came in at 733.71%, down 53963.0% from the prior year.
- Net Margin rose to 332.97% in Q3 2025 per EDIT's latest filing, from 1438.71% in the prior quarter.
- Across five years, Net Margin topped out at 31.41% in Q4 2023 and bottomed at 132683.33% in Q3 2022.
- The 5-year median for Net Margin is 873.2% (2021), against an average of 14653.19%.
- The widest annual swing landed in 2022, when Net Margin plunged 13205237 bps; it then jumped 13183965 bps in 2023.
- Tracing EDIT's Net Margin over 5 years: stood at 332.3% in 2021, then slumped by 180 bps to 929.22% in 2022, then soared by 97 bps to 31.41% in 2023, then tumbled by 372 bps to 148.32% in 2024, then slumped by 124 bps to 332.97% in 2025.
- Per Business Quant, the three latest EDIT Net Margin figures stand at 332.97% (Q3 2025), 1438.71% (Q2 2025), and 1624.37% (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 17.65% |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -332.97% |
| Jun 30, 2025 | -1,438.71% |
| Mar 31, 2025 | -1,624.37% |
| Dec 31, 2024 | -148.32% |
| Sep 30, 2024 | -101,862.30% |
| Jun 30, 2024 | -13,178.56% |
| Mar 31, 2024 | -5,458.68% |
| Dec 31, 2023 | -31.41% |
| Sep 30, 2023 | -843.68% |
| Jun 30, 2023 | -1,395.32% |
| Mar 31, 2023 | -481.70% |
| Dec 31, 2022 | -929.22% |
| Sep 30, 2022 | -132,683.33% |
| Jun 30, 2022 | -843.89% |
| Mar 31, 2022 | -742.59% |
| Dec 31, 2021 | -332.30% |
| Sep 30, 2021 | -630.97% |
| Jun 30, 2021 | -14,579.16% |
| Mar 31, 2021 | -873.20% |
| Dec 31, 2020 | -547.32% |
| Sep 30, 2020 | 12.44% |
| Jun 30, 2020 | -219.29% |
| Mar 31, 2020 | -659.16% |
| Dec 31, 2019 | -307.47% |
| Sep 30, 2019 | -856.06% |
| Jun 30, 2019 | -1,450.04% |
| Mar 31, 2019 | -1,413.68% |
| Dec 31, 2018 | -409.45% |
| Sep 30, 2018 | -104.95% |
| Jun 30, 2018 | -525.27% |
| Mar 31, 2018 | -787.85% |
| Dec 31, 2017 | -986.88% |
| Sep 30, 2017 | -423.42% |
| Jun 30, 2017 | -853.70% |
| Mar 31, 2017 | -4,559.68% |
| Dec 31, 2016 | -4,384.86% |
| Sep 30, 2016 | -2,185.03% |
| Jun 30, 2016 | -562.04% |
| Mar 31, 2016 | -2,210.19% |
| Dec 31, 2015 | -1,607.58% |
| Sep 30, 2015 | -1,120.75% |
| Jun 30, 2015 | -28,543.11% |